“During upcoming World Orphan Drug Congress in Barcelona (https://www.terrapinn.com/conference/world-orphan-drug-congress/agenda.stm), Jiri Hermanek, CEO of ExCEEd Orphan (https://www.exceedorphan.com/) , will join Eversana panel discussion on November 17th covering very important topic of “Navigating Market Access for Advanced Medical Technologies Across Europe – Achieving the Appropriate Balance Between Regional and Local Efforts to Drive Success”
See the panel agenda below:
About ExCEEd Orphan s.r.o.
ExCEEd Orphan was founded in 2018 by five rare disease experts from multiple Central and Eastern European (CEE) countries. The Company is focusing on innovative treatments for rare diseases and has extensive experience in launching innovative medicines in this field. The portfolio of ExCEEd Orphan includes products in therapeutic areas like haematology, neurology, immunology, and metabolic diseases.For further information about ExCEEd Orphan, please visit www.exceedorphan.com